US and French testing services combine forces:
This article was originally published in Clinica
Under a co-operation agreement, NAmSA (US) and Biomatech (France) are providing a variety of testing services for medical devices destined for the US and European markets. Based in Ohio, NAmSA specialises in testing medical devices to meet worldwide regulatory standards and guidelines. Biomatech, located near Lyons, provides services in biocompatibility testing, European regulatory affairs and clinical research.
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.